Grufity logoGrufity logo

IRTC

110.90USD+2.53(+2.33%)Market Closed

Irhythm Technologies Inc

Market Summary

USD110.90+2.53Market Closed
2.33%

IRTC Alerts

IRTC Stock Price

RSI Chart

Valuation

Market Cap

3.9B

Price/Earnings

-29.57

Price/Sales

10.69

Price/Cashflow

-111.63

MarketCap/EBT

-29.62

Price/Sales

Profitability

Operating Margin

66.20%

EBT Margin

-36.08%

Return on Equity

-53.44%

Return on Assets

-30.01%

Fundamentals

Revenue

Revenue (TTM)

380.1M

Revenue Y/Y

21.59%

Revenue Q/Q

1.79%

Earnings

Earnings (TTM)

-128.4M

Earnings Y/Y

9.61%

Earnings Q/Q

10.24%

Price Action

52 Week Range

169.54
(Low)(High)

Last 7 days

5.1%

Last 30 days

-8.5%

Last 90 days

-27.5%

Trailing 12 Months

5.8%

Financial Health

Current Ratio

4.04

Debt/Equity

0.04

Debt/Cashflow

-3.57

Investor Care

Shares Dilution (1Y)

2.33%

Diluted EPS (TTM)

-4.33

Peers (Alternatives to Irhythm Tech)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-11.88% 44.84%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
11.14% 17.68%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-16.73% -66.49%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
26.44% 24.39%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
9.49% -7.06%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-6.64% -29.40%
-16.43
2.57
-8.79% -175.19%

Financials for Irhythm Tech

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue5.1%380362341323320
Gross Profit6.2%254239224214221
Operating Expenses3.4%379367345314298
  S&GA Expenses3.3%307297278275260
  R&D Expenses6.4%4643413938
Earnings Before Taxes1.8%-128.19-130.49-123.87-100.99-78.24
Net Income1.7%-128.45-130.73-124.19-101.36-78.52
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets1.1%440436429463480
  Current Assets0.4%286285286306325
    Cash Equivalents-29.7%7110195128167
  Inventory0.2%1414121010
  Net PPE8.5%7266575653
  Goodwill0%11111
Liabilities5.3%201191184183184
  Current Liabilities18.7%8470628883
  Long Term Debt-10----
    LT Debt, Non Current0.0%3535351013
Shareholder's Equity-2.2%239245245280296
  Retained Earnings-4.5%-502.00-480.55-456.65-406.04-373.55
  Additional Paid-In Capital2.2%742726702686669
Accumulated Depreciation9.6%3229262321
Shares Outstanding0.4%3030302929
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-40.5%-48.63-34.62-34.80-37.75-16.89
  Share Based Compensation1.5%5453485557
Cashflow From Investing-218.5%-71.45-22.43-20.30105115
Cashflow From Financing23.2%241913-28.58-25.99

Risks

What is the probability of a big loss on IRTC?

83.5%


Probability that Irhythm Tech stock will be more than 20% underwater in next one year

65.8%


Probability that Irhythm Tech stock will be more than 30% underwater in next one year.

24.6%


Probability that Irhythm Tech stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IRTC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Irhythm Tech was unfortunately bought at previous high price.

Returns

Cumulative Returns on IRTC

15.8%


5-Year Cumulative Returns

15.3%


3-Year Cumulative Returns

What are the long-term rolling returns for IRTC?

FIve years rolling returns for Irhythm Tech.

Which funds bought or sold IRTC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
599,000
4,688,000
0.01%
2022-11-18
Industrial Alliance Investment Management Inc.
NEW
-
3,945,000
3,945,000
0.12%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-101,000
-
-%
2022-11-15
STATE STREET CORP
ADDED
0.91
12,926,000
88,867,000
0.01%
2022-11-15
Baird Financial Group, Inc.
NEW
-
2,187,000
2,187,000
0.01%
2022-11-15
IMA Wealth, Inc.
UNCHANGED
-
94,000
677,000
0.18%
2022-11-15
NOMURA HOLDINGS INC
ADDED
65.86
2,059,000
4,429,000
0.02%
2022-11-15
CASTLEARK MANAGEMENT LLC
REDUCED
-9.32
222,000
4,523,000
0.25%
2022-11-15
Bradley Mark J.
ADDED
0.7
387,000
2,695,000
2.50%
2022-11-15
ALLIANCEBERNSTEIN L.P.
ADDED
14.86
40,787,000
163,617,000
0.08%

1–10 of 40

Latest Funds Activity

Are funds buying IRTC calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own IRTC

Irhythm Tech News

Digital Journal

Healthcare Wearable Device Market 2022 Clinical Insights and Growth Opportunities – Pebble Technology Corp., Apple, Vuzix Corporation (VUZI)+, Sony Corp (SNE).44 hours ago

IRTC Fair Value

Recent SEC filings of Irhythm Tech

View All Filings
Date Filed Form Type Document
Nov 21, 2022
4/A
Insider Trading
Nov 21, 2022
4/A
Insider Trading
Nov 07, 2022
SC 13G/A
Major Ownership Report
Nov 04, 2022
4
Insider Trading
Nov 04, 2022
10-Q
Quarterly Report
Nov 01, 2022
8-K
Current Report
Sep 28, 2022
4
Insider Trading
Sep 21, 2022
8-K
Current Report
Sep 14, 2022
4
Insider Trading

Latest Insider Trading transactions for IRTC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-02
Blackford Quentin S.
SOLD
-1,554,400
122.403
-12,699
President and CEO
2022-09-26
Wilson Daniel G.
SOLD
-367,716
122.572
-3,000
EVP, Strategy Corp Dev Inv Rel
2022-09-12
Bairey Merz Cathleen Noel
SOLD
-14,379.3
159.77
-90
-
2022-08-08
Bobzien Brice
ACQUIRED
-
-
10,129
Chief Financial Officer
2022-07-25
Fernandez Reyna M
ACQUIRED
-
-
7,654
EVP, Chief HR Officer
2022-07-25
Patterson Chad
ACQUIRED
-
-
21,050
Chief Commercial Officer
2022-07-25
Patterson Chad
ACQUIRED
-
-
20,789
Chief Commercial Officer
2022-07-25
Fernandez Reyna M
ACQUIRED
-
-
7,559
EVP, Chief HR Officer
2022-07-07
Devine Douglas
SOLD
-1,154,650
114.22
-10,109
Chief Operating Officer & CFO
2022-07-05
Devine Douglas
SOLD
-134,925
108.898
-1,239
Chief Operating Officer & CFO

1–10 of 50

Quentin S. Blackford
1700
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Income Statement

2022-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue, net$ 103,875$ 85,432$ 298,304$ 241,021
Cost of revenue32,95429,28495,37978,737
Gross profit70,92156,148202,925162,284
Operating expenses:    
Research and development11,4488,68533,93526,801
Selling, general and administrative80,55970,745235,468203,227
Impairment and restructuring charges0026,6080
Total operating expenses92,00779,430296,011230,028
Loss from operations(21,086)(23,282)(93,086)(67,744)
Interest expense(614)(279)(3,125)(921)
Other income (expense), net365(76)450103
Loss before income taxes(21,335)(23,637)(95,761)(68,562)
Income tax provision11694196308
Net loss$ (21,451)$ (23,731)$ (95,957)$ (68,870)
Net loss per common share, basic (in USD per share)$ (0.71)$ (0.81)$ (3.22)$ (2.35)
Net loss per common share, diluted (in USD per share)$ (0.71)$ (0.81)$ (3.22)$ (2.35)
Weighted-average shares, basic (in shares)30,055,16629,397,84529,836,60129,294,559
Weighted-average shares, diluted (in shares)30,055,16629,397,84529,836,60129,294,559

IRTC Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 71,222$ 127,562
Short-term investments132,316111,569
Accounts receivable, net60,53446,430
Inventory14,45210,268
Prepaid expenses and other current assets7,3269,693
Total current assets285,850305,522
Property and equipment, net71,51555,944
Operating lease right-of-use assets62,01084,587
Goodwill862862
Other assets20,15316,052
Total assets440,390462,967
Current liabilities:  
Accounts payable7,40410,509
Accrued liabilities60,26451,486
Deferred revenue3,0033,049
Debt, current portion011,667
Operating lease liabilities, current portion12,92011,142
Total current liabilities83,59187,853
Debt, noncurrent portion34,9319,690
Other noncurrent liabilities1,163697
Operating lease liabilities, noncurrent portion81,48185,212
Total liabilities201,166183,452
Commitments and contingencies (Note 7)
Stockholders’ equity:  
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2022 and December 31, 202100
Common stock, $0.001 par value; 100,000,000 shares authorized; 30,094,205 shares at September 30, 2022 and 29,493,726 at December 31, 2021 issued and outstanding2827
Additional paid-in capital741,879685,594
Accumulated other comprehensive loss(681)(61)
Accumulated deficit(502,002)(406,045)
Total stockholders’ equity239,224279,515
Total liabilities and stockholders’ equity$ 440,390$ 462,967